Zydus Cadila on Wednesday launched Ramelteon tablets, used to treat insomnia, in the US market.
In a BSE filing, Zydus Cadila announced the “launch of Ramelteon tablets, 8 mg upon receiving the final approval from the USFDA. Ramelteon is a sedative, also called a hypnotic“.
Ramelteon is used to treat insomnia that is associated with having trouble falling asleep.
Zydus Cadila said the drug will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.
The Gujarat-based group has more than 270 USFDA approvals and has filed over 360 abbreviated new drug applications (ANDAs), since it commenced filings in 2003-04.
Shares of Cadila Healthcare, the groups listed entity, were trading 1.48 per cent lower at Rs 232.20 apiece on BSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.